Tasly Pharmaceutical Group Co Ltd

600535 • SHG

¥13.86¥0.00 (0%)

Estimate

P/E

17.8

EPS

0.78

Beta

0.215

Growth

Revenue, YoY

5.35%

Net income, YoY

17.8%

FCF, YoY

179.39%

Forecast

P/E (FWD)

12.9

EPS (FWD)

1.077

About the company

Ticker

600535

ISIN

CNE000001C81

Country

China

Sector (GICS)

Healthcare

Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.

Frequently asked questions

What sector does Tasly Pharmaceutical Group Co Ltd (600535) operate in?

Tasly Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Tasly Pharmaceutical Group Co Ltd (600535) current stock price?

As of the latest data, Tasly Pharmaceutical Group Co Ltd stock price is CN¥13.86, with a previous close of CN¥13.86.

What is Tasly Pharmaceutical Group Co Ltd (600535) current market capitalization?

Tasly Pharmaceutical Group Co Ltd market cap is approximately 20.71 billion.

What is Tasly Pharmaceutical Group Co Ltd (600535) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.78, and the forward EPS is CN¥1.08.

What is Tasly Pharmaceutical Group Co Ltd (600535) Price-to-Earnings (P/E) ratio?

Tasly Pharmaceutical Group Co Ltd current P/E ratio is 17.77, with a forward P/E of 12.87.

Does Tasly Pharmaceutical Group Co Ltd (600535) pay dividends?

No. Tasly Pharmaceutical Group Co Ltd does not pay a dividend.

How did Tasly Pharmaceutical Group Co Ltd (600535) perform in its most recent earnings report?

In the last report (June 30, 2026), Tasly Pharmaceutical Group Co Ltd posted an EPS surprise of -3.85% and a revenue surprise of -6.81%.

What is Tasly Pharmaceutical Group Co Ltd (600535) beta (volatility) score?

Tasly Pharmaceutical Group Co Ltd has a beta of 0.215, indicating lower volatility than the overall market.